149 related articles for article (PubMed ID: 21674145)
1. Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications.
Han Y; Zhu L; Sun A; Lu X; Hu L; Zhou L; Ren Y; Hu X; Wu X; Wang Z; Ruan C; Wu D
Ann Hematol; 2011 Oct; 90(10):1201-8. PubMed ID: 21674145
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of plasminogen activator inhibitor-1 (PAI-1) in the early development of HSCT-associated thrombotic complications.].
Han Y; Lu XX; Wu DP; Sun AN; Zhang W; Hu XH; Gao HL; Wang ZY; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):731-4. PubMed ID: 20137306
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of TNF-alpha, IL-1beta and IFN-gamma levels at early phase after allogeneic hematopoietic stem cell transplantation].
Gao HL; Sun AN; Han Y; Zhang W; Hu XH; Wu DP; Ruan CG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1321-5. PubMed ID: 19840475
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.
Pihusch M; Wegner H; Goehring P; Salat C; Pihusch V; Hiller E; Andreesen R; Kolb HJ; Holler E; Pihusch R
Transplantation; 2005 Nov; 80(10):1376-82. PubMed ID: 16340778
[TBL] [Abstract][Full Text] [Related]
5. Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population.
Sartori MT; Spiezia L; Cesaro S; Messina C; Paris M; Pillon M; Saggiorato G; Pagnan A; Girolami A; Zanesco L; Cella G
Thromb Haemost; 2005 Apr; 93(4):682-9. PubMed ID: 15841312
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy.
Kanamori H; Maruta A; Sasaki S; Yamazaki E; Ueda S; Katoh K; Tamura T; Otsuka-Aoba M; Taguchi J; Harano H; Ogawa K; Mohri H; Okubo T; Matsuzaki M; Watanabe S; Koharazawa H; Fujita H; Kodama F
Bone Marrow Transplant; 1998 Apr; 21(7):705-9. PubMed ID: 9578311
[TBL] [Abstract][Full Text] [Related]
7. Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation.
Rank A; Nieuwland R; Toth B; Pihusch V; Delker R; Hiller E; Kolb HJ; Pihusch R
Transplantation; 2011 Jul; 92(2):244-50. PubMed ID: 21629178
[TBL] [Abstract][Full Text] [Related]
8. Associations between acute GVHD-related biomarkers and endothelial cell activation after allogeneic hematopoietic stem cell transplantation.
Nomura S; Ishii K; Fujita S; Nakaya A; Satake A; Ito T
Transpl Immunol; 2017 Aug; 43-44():27-32. PubMed ID: 28687251
[TBL] [Abstract][Full Text] [Related]
9. A Novel Diagnostic and Prognostic Biomarker Panel for Endothelial Cell Damage-Related Complications in Allogeneic Transplantation.
Tatekawa S; Kohno A; Ozeki K; Watamoto K; Ueda N; Yamaguchi Y; Kobayashi T; Yokota I; Teramukai S; Taniwaki M; Kuroda J; Morishita Y
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1573-1581. PubMed ID: 27246373
[TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
11. Predictive Values of Early Suppression of Tumorigenicity 2 for Acute GVHD and Transplant-related Complications after Allogeneic Stem Cell Transplantation: Prospective Observational Study.
Matsumura A; Miyazaki T; Tachibana T; Ando T; Koyama M; Koyama S; Ishii Y; Takahashi H; Nakajima Y; Numata A; Yamamoto W; Motohashi K; Hagihara M; Matsumoto K; Fujisawa S; Nakajima H
Turk J Haematol; 2020 Feb; 37(1):20-29. PubMed ID: 31464120
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic and hemorrhagic complications in children and young adult recipients of Hematopoietic Stem Cell Transplant (HSCT).
Kaur D; Ashrani AA; Pruthi R; Khan SP; Bailey K; Rodriguez V
Thromb Res; 2018 Jul; 167():44-49. PubMed ID: 29787942
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin-3 levels in graft-versus-host disease during allogeneic hematopoietic stem cell transplantation.
Doehn JM; Winkler A; Kuzmina Z; Hladik A; Greinix H; Knapp S; Robak O
Exp Hematol; 2016 Oct; 44(10):917-23. PubMed ID: 27403536
[TBL] [Abstract][Full Text] [Related]
14. Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.
Pihusch M; Lohse P; Reitberger J; Hiller E; Andreesen R; Kolb HJ; Holler E; Pihusch R
Transplantation; 2004 Sep; 78(6):911-8. PubMed ID: 15385813
[TBL] [Abstract][Full Text] [Related]
15. Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.
Tanikawa S; Mori S; Ohhashi K; Akiyama H; Sasaki T; Kaku H; Hiruma K; Matsunaga T; Morita T; Sakamaki H
Bone Marrow Transplant; 2000 Oct; 26(8):881-6. PubMed ID: 11081389
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of tissue plasminogen activator (t-PA) and tissue plasminogen activator inhibitor (PAI) correlate with tumor necrosis factor alpha (TNF alpha)-release in patients suffering from microangiopathy following allogeneic bone marrow transplantation (BMT).
Seeber C; Hiller E; Holler E; Kolb HJ
Thromb Res; 1992 May; 66(4):373-83. PubMed ID: 1412203
[TBL] [Abstract][Full Text] [Related]
17. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
19. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Gavriilaki E; Bousiou Z; Batsis I; Vardi A; Mallouri D; Koravou EE; Konstantinidou G; Spyridis N; Karavalakis G; Noli F; Patriarcheas V; Masmanidou M; Touloumenidou T; Papalexandri A; Poziopoulos C; Yannaki E; Sakellari I; Politou M; Papassotiriou I
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203404
[TBL] [Abstract][Full Text] [Related]
20. Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?
Villalón L; Avello AG; César J; Odriozola J; López J; Oteyza JP; Laraña JG; Cantalapiedra A; Navarro JL
Thromb Res; 2000 Sep; 99(5):439-46. PubMed ID: 10973671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
